Eli Kotler

Eli Kotler is a consultant psychiatrist and Fellow of the Royal Australian and New Zealand College of Psychiatrists who holds the distinction of being the first psychiatrist in Australia to treat a patient with psychedelic-assisted therapy. He completed his Bachelor of Medicine and Surgery at Monash University in 2004, a Masters of Psychiatry at the University of Melbourne in 2011, and attained FRANZCP fellowship in 2013. Kotler serves as Medical Director and Consultant Psychiatrist at Malvern Private Hospital in Melbourne and holds an adjunct lectureship at Monash University through the Alfred Psychiatry Research Centre. As a director and board member of Mind Medicine Australia, he has been instrumental in shaping the national framework for psychedelic-assisted therapies. He currently leads an MDMA-assisted psychotherapy trial for post-traumatic stress disorder sponsored by Emyria and is an authorized prescriber of both MDMA and psilocybin under Australia's Therapeutic Goods Administration scheme. In 2021, he challenged the Victorian government in court to secure patient access to psychedelic-assisted therapy, a landmark action that contributed to broader regulatory change.